If you liked this article you might like

Clovis, Tesaro Soar on Astrazeneca Phase Three News
Morgan Stanley, Twitter, Tesaro: Doug Kass' Views
Biotech Tesaro Climbs on Takeout Reports
4 Biotech Names That Could Be M&A Targets